Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor-derived CMV-specific T cells
Ingels, J.; De Smet, S.; Heyns, K.et al.
2021 • In Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine, 76, p. 482-486
Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor derived CMV specific T cells.pdf
Ingels, J.; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium, Cell Therapy Unit, Department of Regenerative Medicine, Ghent University Hospital, Ghent, Belgium
De Smet, S.; Cell Therapy Unit, Department of Regenerative Medicine, Ghent University Hospital, Ghent, Belgium
Heyns, K.; Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium
Lootens, N.; Cell Therapy Unit, Department of Regenerative Medicine, Ghent University Hospital, Ghent, Belgium
Segaert, J.; Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium
Taghon, T.; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
Leclercq, G.; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
Vermaelen, K.; Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium
WILLEMS, Evelyne ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'hématologie clinique
BAUDOUX, Etienne ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Laboratoire de thérapie cellulaire et génique (LTCG)
Kerre, T.; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium, Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium
Vandekerckhove, B.; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium, Cell Therapy Unit, Department of Regenerative Medicine, Ghent University Hospital, Ghent, Belgium
Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor-derived CMV-specific T cells
Publication date :
2021
Journal title :
Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine
Green ML, Leisenring W, Xie H, et al. Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study. Lancet Haematol. 2016; 3: e119–e127.
Chang Y-J, Zhao X-Y, Huo M-R, et al. Immune reconstitution following unmanipulated HLA-mismatched/haploidentical transplantation compared with HLA-identical sibling transplantation. J Clin Immunol. 2012; 32: 268–280.
Liu J, Kong J, Chang YJ, et al. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality. Clin Microbiol Infect. 2015; 21: 1121.e9-1121.e15.
Ahmed A. Antiviral treatment of cytomegalovirus infection. Infect Disord - Drug Targets. 2011; 11: 475–503.
Cwynarski K, Ainsworth J, Cobbold M, et al. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood. 2001; 97: 1232–1240.
Feuchtinger T, Opherk K, Bethge WA, et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood. 2010; 116: 4360–4367.
Einsele H, Roosnek E, Rufer N, et al. Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood. 2002; 99: 3916–3922.
Chou S, Ercolani RJ, Sahoo MK, et al. Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing. Antimicrob Agents Chemother. 2014; 58: 4697–4702.
Laidlaw BJ, Craft JE, Kaech SM. The multifaceted role of CD4+ T cells in CD8+ T cell memory. Nat Rev Immunol. 2016; 16: 102–111.
Janeway’s Immunobiology. Ninth Edition. By Kenneth Murphy and Casey Weaver; with contributions by Allan Mowat, Leslie Berg, and David Chaplin; with acknowledgment to: charles A. Janeway, Jr., Paul Travers, and Mark Walport. New York: Garland Science. Tay Q Rev Biol. 2018; 93: 59.
Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev. 2009; 22: 76–98.
Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 1995; 333: 1038–1044.